Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikuma Hamada

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 3, 2014
Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationaleMasato Nakamura, Shinsuke Nanto, Atsushi Hirayama, et al.
Modern Rheumatology|January 7, 2020
Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC studyYoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, et al.
Arthritis Research & Therapy|July 22, 2018
Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC studyYoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, et al.
Annals of Surgery|September 25, 2012
Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysisTomohiko Iida, Hiroaki Nomori, Mitsutoshi Shiba, et al.
Oncotarget|December 13, 2017
Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trialsMichitaka Honda, Koji Oba, Takashi Akiyoshi, et al.
The Lancet. Oncology|September 7, 2012
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trialTakayuki Yoshino, Nobuyuki Mizunuma, Kentaro Yamazaki, et al.
British Journal of Cancer|March 6, 2019
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 studyNaohiro Tomita, Katsuyuki Kunieda, Atsuyuki Maeda, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2014
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trialTakashi Tsuchiya, Sotaro Sadahiro, Kazuaki Sasaki, et al.
The Lancet. Neurology|September 14, 2010
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trialYukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 14, 2014
Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2Shinichiro Uchiyama, Yukito Shinohara, Yasuo Katayama, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 3, 2014
Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationaleMasato Nakamura, Shinsuke Nanto, Atsushi Hirayama, et al.
Modern Rheumatology|January 7, 2020
Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC studyYoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, et al.
Arthritis Research & Therapy|July 22, 2018
Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC studyYoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, et al.
Annals of Surgery|September 25, 2012
Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysisTomohiko Iida, Hiroaki Nomori, Mitsutoshi Shiba, et al.
Oncotarget|December 13, 2017
Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trialsMichitaka Honda, Koji Oba, Takashi Akiyoshi, et al.
The Lancet. Oncology|September 7, 2012
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trialTakayuki Yoshino, Nobuyuki Mizunuma, Kentaro Yamazaki, et al.
British Journal of Cancer|March 6, 2019
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 studyNaohiro Tomita, Katsuyuki Kunieda, Atsuyuki Maeda, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2014
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trialTakashi Tsuchiya, Sotaro Sadahiro, Kazuaki Sasaki, et al.
The Lancet. Neurology|September 14, 2010
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trialYukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 14, 2014
Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2Shinichiro Uchiyama, Yukito Shinohara, Yasuo Katayama, et al.
Pageof 10